Patient-derived xenograft model of well-differentiated pancreatic neuroendocrine tumor in immunodeficient Balb/c Nude mice
Background: Orthotopic patient-derived xenografts (PDX) in immunodeficient mice are recognized as the most adequate neoplastic model due to their ability to maintain primary tumor properties after implantation. They can be used to study anti-neoplastic effects of pharmacological substances in vivo a...
Main Authors: | V. S. Trifanov, A. Yu. Maksimov, A. S. Goncharova, E. A. Lukbanova, N. S. Karnaukhov, S. O. Kit, A. V. Volkova, T. P. Protasova, S. Yu. Tkachev, D. V. Khodakova, E. V. Zaikina, M. V. Mindar, I. M. Akulshina |
---|---|
Format: | Article |
Language: | Russian |
Published: |
MONIKI
2020-07-01
|
Series: | Alʹmanah Kliničeskoj Mediciny |
Subjects: | |
Online Access: | https://www.almclinmed.ru/jour/article/view/1323 |
Similar Items
-
Patient-Derived Orthotopic Xenograft Models of Pediatric Brain Tumors: In a Mature Phase or Still in Its Infancy?
by: Eva Hermans, et al.
Published: (2020-01-01) -
Generation of glioblastoma patient-derived organoids and mouse brain orthotopic xenografts for drug screening
by: Christian Moya Gamboa, et al.
Published: (2021-03-01) -
A fast, simple, and cost-effective method of expanding patient-derived xenograft mouse models of pancreatic ductal adenocarcinoma
by: Zhenyang Liu, et al.
Published: (2020-06-01) -
Development of a Novel Orthotopic Gastric Cancer Mouse Model
by: Wonyoung Kang, et al.
Published: (2021-01-01) -
Novel Breast Cancer Brain Metastasis Patient-Derived Orthotopic Xenograft Model for Preclinical Studies
by: Masanori Oshi, et al.
Published: (2020-02-01)